n.boateng
TL2 · Angers
Contributes reviews on supplier material. Based in Angers.
Joined 14 December 2024 · last posted 6d
79 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #85 · Outcomes › Progress reports · 22 Jul 2026 · 12 likes Coming back to post #83, because the follow-up matters more than the original answer. Something worth flagging about seven-day rolling: the strongest-sounding claims in…
-
Spreadsheets: an appreciation — what changed since Replied, post #99 · Lounge › Off topic · 13 Jul 2026 · 1 like Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. I would want a…
-
How to ask a question when you cannot say why you are asking it Replied, post #35 · Start Here › How to Ask · 9 Jul 2026 · 1 like Coming back to post #33, because the follow-up matters more than the original answer. Do not apologise in the first line. It costs you the space where the question…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #58 · Evidence › Journal club · 5 Jul 2026 · 0 likes Picking up post #55: that is the part I would want checked first. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
Pages past their review date, listed — does this still hold? Replied, post #29 · Meta › Wiki maintenance · 28 Jun 2026 · 3 likes Narrowing post #28, because the general version has more than one answer. Two people in this thread mean different things by Pages past and are disagreeing about the…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #11 · Start Here › How to Ask · 28 Jun 2026 · 14 likes Answering the question post #9 raises rather than the one it answers. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #39 · Evidence › Journal club · 16 Jun 2026 · 12 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #103 · Practice › Reconstitution · 12 Jun 2026 · 4 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Revisiting: The best-written scientific paper you have read Replied, post #24 · Lounge › Off topic · 10 Jun 2026 · 14 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #42 · Practice › Storage & stability · 1 Jun 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
What published stability data actually covers, and what it does not Replied, post #3 · Practice › Storage & stability · 23 May 2026 · 12 likes Narrowing post #2, because the general version has more than one answer. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
-
Reading a trial's population section before its results Replied, post #25 · Evidence › Trials · 16 May 2026 · 7 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #118 · Practice › Reconstitution · 30 Apr 2026 · 10 likes This follows post #115 rather than contradicting it. Where the Foaming during reconstitution discussion usually stalls is that nobody wants to say "I do not know" and…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #8 · Analytics › Mass spectrometry · 29 Apr 2026 · 10 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #6 · Practice › Storage & stability · 26 Apr 2026 · 22 likes Everything in post #2 holds. The case it does not cover is the one I have. Temperature excursions in transit are common and are not all equal. A few hours warm is a…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #16 · Practice › Reconstitution · 18 Apr 2026 · 1 like That reframing is the whole thing. The facts I already had.
-
List price versus negotiated price versus what you pay Replied, post #113 · Access › Pricing · 17 Apr 2026 · 1 like Price differences within a market are usually about scale, documentation and logistics rather than about anything mysterious. Written from notes rather than memory,…
-
List price versus negotiated price versus what you pay Replied, post #95 · Access › Pricing · 16 Apr 2026 · 3 likes Where somebody posts a comparison, the useful version states the date, the region and what was included. Not a strong opinion, just a consistent one.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #61 · Start Here › Welcome · 3 Apr 2026 · 12 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #7 · Practice › Dosing & titration · 14 Mar 2026 · 0 likes Doubling after a miss adds a peak for no gain and is not what any labelling in this class recommends. That is a description of the labelling rather than advice about…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #37 · Lounge › Introductions · 11 Mar 2026 · 0 likes Welcome aboard. If you post an introduction and then nothing for a month, nobody notices and nobody minds. Come back when there is something you want to know.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #19 · Compounds › Repair & healing peptides · 8 Mar 2026 · 20 likes The documentation on Stability of BPC-157 is better than this thread and I say that as someone who has posted in the thread.
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #61 · Data & Tools › Calculators · 2 Mar 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Manufacturer assistance programmes and their eligibility rules Replied, post #8 · Access › Pricing · 28 Feb 2026 · 0 likes Nobody has said the unglamorous part of manufacturer assistance programmes yet, so: most of the variation is explained by things that are boring to write about and easy…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #14 · Practice › Administration · 30 Jan 2026 · 30 likes Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting one area changes the local tissue over time and eventually changes…
-
Waist circumference technique and its repeatability Replied, post #38 · Outcomes › Progress reports · 13 Jan 2026 · 8 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. Written from notes rather than memory, which is why…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #41 · Devices › Pens & autoinjectors · 9 Jan 2026 · 3 likes Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people miss. It is on the carton. Genuinely open to being…
-
Aggregates and why a purity assay may miss them entirely Replied, post #51 · Analytics › Impurities & related substances · 5 Jan 2026 · 12 likes The version of aggregates that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
-
Guidelines revision: what changed and why — one year on Replied, post #53 · Meta › Announcements · 1 Jan 2026 · 12 likes On post #51 — agreed on the reasoning, with one qualification. Supportive, with one reservation worth stating in public: the change makes a common case slightly slower…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #50 · Sourcing › Vendor reports · 26 Dec 2025 · 3 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Personal import allowances, compared Replied, post #9 · Access › International · 21 Dec 2025 · 3 likes Adding what did not work for me on personal import allowances, since the failures never get written up and they are half the useful information.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #7 · Practice › Reconstitution · 11 Dec 2025 · 0 likes Agreed on reconstitution volumes, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
-
Absence of evidence and evidence of absence Replied, post #7 · Research Methods › Statistics · 29 Nov 2025 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Number needed to treat: how many people need to be treated to prevent one bad…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #5 · Compounds › Oral incretins · 27 Oct 2025 · 10 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
Payment mechanics and the recovery options that do not exist Replied, post #70 · Sourcing › Payments · 22 Oct 2025 · 0 likes Building on post #69 rather than restating it. Adding a reference point for payment mechanics. Mine is a single case, collected without controls, and I am posting the…
-
About the North America category Replied, post #5 · Regional › North America · 10 Oct 2025 · 3 likes Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end. That has held every time I have…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #45 · Practice › Storage & stability · 19 Sep 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Request: show the solution author in the topic list Replied, post #3 · Meta › Feature requests · 14 Sep 2025 · 24 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #45 · Data & Tools › Datasets · 8 Sep 2025 · 17 likes Where I would push back on the Aggregated purity results across four consensus is the confidence, not the direction. The direction looks right. The confidence is…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #13 · Start Here › How to Ask · 8 Sep 2025 · 0 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #13 · Evidence › Journal club · 4 Sep 2025 · 13 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #20 · Practice › Side effects · 27 Aug 2025 · 0 likes A methods point on nausea timeline rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #26 · Compounds › Oral incretins · 10 Aug 2025 · 7 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. Oral versus injectable exposure: comparing a 14 mg oral dose with…
-
How to research a compound with no human data without deceiving yourself Replied, post #25 · Compounds › Other compounds · 31 Jul 2025 · 0 likes Reading back through the research a compound threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #3 · Data & Tools › Calculators · 30 Jul 2025 · 10 likes Thank you — that answers what I came here to find out.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #13 · Compounds › Secretagogues & GH axis · 26 Jul 2025 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #136 · Compounds › Tirzepatide · 14 Jul 2025 · 2 likes Thank you for taking the time. That was more work than a reply usually is.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #43 · Sourcing › Regulatory · 6 Jul 2025 · 5 likes Picking up post #42: that is the part I would want checked first. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #76 · Practice › Storage & stability · 1 Jul 2025 · 0 likes Post #72 describes the usual case. This is about the unusual one. My understanding of published stability data actually covers is a few years old and may have been…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #19 · Compounds › Secretagogues & GH axis · 27 Jun 2025 · 7 likes Noted, and thank you for writing it out rather than summarising it.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #13 · Practice › Reconstitution · 18 Jun 2025 · 0 likes A request rather than an answer: could whoever has the primary source for decimal-point error post it? I have seen the claim three times this month and each version had…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #91 · Access › Insurance & coverage · 13 Jun 2025 · 2 likes Everything in post #89 holds. The case it does not cover is the one I have. Documentation your clinician can provide: letters from clinicians describing why standard…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #9 · Analytics › Method validation · 5 Jun 2025 · 13 likes Thank you — that answers what I came here to find out.
-
Publishing an inconvenient result: a case study Replied, post #28 · Sourcing › Independent verification · 2 Jun 2025 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #70 · Outcomes › Body composition · 20 May 2025 · 16 likes Lean mass in these measurements includes water, so a change in hydration appears as a change in lean mass.
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #65 · Compounds › Secretagogues & GH axis · 19 May 2025 · 0 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #9 · Clinical › Special populations · 15 May 2025 · 10 likes Counterpoint on History of disordered eating, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #16 · Clinical › Bloodwork · 7 May 2025 · 2 likes The most useful thing this subcategory does is help people tell an interesting result from an uninteresting one before booking an appointment about it.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 1 May 2025 · 4 likes Marking my place. If it changes for me I will come back and say so.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #38 · Data & Tools › Calculators · 28 Apr 2025 · 0 likes Building on post #35 rather than restating it. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input gives a…
-
Carryover and the ghost peak from last week's standard Replied, post #80 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 5 likes I have been on both sides of the carryover argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Carryover and the ghost peak from last week's standard Replied, post #9 · Analytics › HPLC & UHPLC · 1 Apr 2025 · 4 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #94 · Access › International · 12 Mar 2025 · 19 likes Understood, and I withdraw the assumption I opened with.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #2 · Wellbeing › Mental health · 1 Feb 2025 · 4 likes On the opening post — agreed on the reasoning, with one qualification. The social side of this — how other people respond to visible change — comes up constantly and…
-
Fixed versus detachable needles: the trade-offs Replied, post #120 · Devices › Syringes & needles · 18 Jan 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #18 · Compounds › Oral incretins · 3 Jan 2025 · 26 likes Worth separating two things that post #16 runs together. Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a…
-
Isotonicity and what happens when you get it wrong Replied, post #11 · Pharmacology › Formulation chemistry · 28 Dec 2024 · 10 likes Isotonicity matters for comfort at injection and does not matter for stability. Those two get conflated when people compare diluents.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #8 · Compounds › Other compounds · 28 Dec 2024 · 31 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
What we do not know about retatrutide, listed explicitly Replied, post #35 · Compounds › Retatrutide · 28 Dec 2024 · 19 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Body image changing more slowly than the body Replied, post #127 · Wellbeing › Mental health · 25 Dec 2024 · 5 likes Filing a mild objection to the consensus on body image. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Revisiting: Moderation log format change Replied, post #63 · Meta › Announcements · 11 Dec 2024 · 0 likes Supportive, with one reservation worth stating in public: the change makes a common case slightly slower in exchange for making a rare case much better. That is usually…
-
Criticising the method without criticising the authors Replied, post #22 · Evidence › Study critique · 6 Dec 2024 · 33 likes Seconded. It reads as careful rather than confident, which is the right register.
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #44 · Clinical › Prescriber conversations · 9 Nov 2024 · 4 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea…
-
Time to steady state after a dose increase Replied, post #143 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 8 likes Where I part company with post #139, and it is a narrow parting. A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #8 · Clinical › Comorbidities · 8 Oct 2024 · 3 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
-
How to ask for a dose change without antagonising anyone Replied, post #23 · Clinical › Prescriber conversations · 7 Sep 2024 · 28 likes Post #19 and I disagree about the size of the effect, not about the direction. Discussing off-label dosing: if you want to dose differently than the label specifies…
-
Promotion criteria, and the one that stops most nominations Replied, post #50 · Documentation › Doc review · 31 Aug 2024 · 0 likes The reason promotion criteria is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #80 · Evidence › Journal club · 29 Jul 2024 · 0 likes What I would want before treating LEADER as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Assessing a warm arrival: the decision process — one year on Replied, post #105 · Sourcing › Logistics · 1 Jun 2024 · 21 likes Post #104 is the version of this I will quote in future. One addition. Documentation after arrival: photograph the parcel and its contents on arrival. If something…